PERIPLOCYMARIN (BRD-A45333398)
Overview
- pert_id
- BRD-A45333398
- Name
- periplocymarin
- Collection
- BIOA
- MOA
- Unknown
- Target(s)
- Unknown
- Indication(s)
- Unknown
- Phase
- Unknown
- Canonical SMILES
- CO[C@@H]1C[C@H](O[C@H]2CC[C@]3(C)C4CC[C@]5(C)[C@H](CC[C@]5(O)[C@@H]4CC[C@]3(O)C2)C6=CC(=O)OC6)O[C@H](C)[C@@H]1O
- InChI key
- InChIKey=XRWQBDJPMXRDOQ-IDULJFIXSA-N
- InChI string
- InChI=1S/C30H46O8/c1-17-26(32)23(35-4)14-25(37-17)38-19-5-9-27(2)21-6-10-28(3)20(18-13-24(31)36-16-18)8-12-30(28,34)22(21)7-11-29(27,33)15-19/h13,17,19-23,25-26,32-34H,5-12,14-16H2,1-4H3/t17-,19+,20-,21?,22-,23-,25+,26+,27-,28-,29+,30+/m1/s1
- Molecular formula
- C30H46O8
- Molecular weight
- 534.681
External links
- PubChem
- 6708762
- Wikipedia
- http://www.chemicalbook.com/ChemicalProductProperty_EN_CB01483233.htm
- SEP-L1000
- BRD-A45333398
Predicted MOAs
| MOA | Probability |
|---|---|
| protein synthesis inhibitor | 0.4097 |
| NFkB pathway inhibitor | 0.1491 |
| glucocorticoid receptor agonist | 0.0831 |
| tubulin polymerization inhibitor | 0.0366 |
| mTOR inhibitor | 0.0270 |
| CDK inhibitor | 0.0266 |
| PI3K inhibitor | 0.0264 |
| HSP inhibitor | 0.0217 |
| topoisomerase inhibitor | 0.0189 |
| cyclooxygenase inhibitor | 0.0188 |
Chemical structure
